Self – Lollisponge™
LolliSponge™ easiness allows saliva collection from non-collaborative patients or when professional assistance is not available, enabling COVID-19 active surveillance programs in fragile communities.
Copan Universal Transport Medium (UTM®) system is intended for the collection, transport, and preservation of clinical specimens containing Viruses, Chlamydia, Mycoplasma, and Ureaplasma.
eNAT® is intended to collect, transport, and preserve microbial and human nucleic acids to be analyzed by amplification techniques. With its rapid analysis and inactivation features, eNAT® is the ready-to-use device to quickly homogenize your sample, for a high-quality, unbiased nucleic acid yield, and fast turnaround time.
FLOQSwabs® consists of a customizable molded plastic shaft and a tip coated with perpendicular short Nylon® fibers. Thanks to the superior elution efficiency, FLOQSwabs® ensure a flawless specimen collection, expanding downstream testing capabilities.
The FLOQ® technology answers the healthcare professionals’ need for a more efficient sample collection. The FLOQ® patented arrangement of Nylon® fibers offers superior performance, bringing sampling to the next level.
Molecular Lab Automation
Molecular assays have, in some instances, replaced traditional testing methods, and they are now an integral part of infectious diseases screening, diagnosis, and management.
Respiratory tract infections are among the most common disorders affecting today’s population, representing the third cause of death in the whole world.
SLSolution™ is the answer to the sputum processing problem, as its mucolytic activity rapidly liquefies sputum without affecting the vitality and the morphology of bacteria and fungi.
Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen—new tool to detect infective COVID-19 patients
Lorena Porte, Paulette Legarraga, Mirentxu Iruretagoyena, Valeska Vollrath, Gabriel Pizarro, Jose Munita, Rafael Araos, Thomas Weitzel
Chest CT accuracy in diagnosing COVID-19 during the peak of the Italian epidemic: A retrospective correlation with RT-PCR testing and analysis of discordant cases
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19)
Egildo Luca D’andrea et al.
Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing
Shairaz Baksh et al.
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy
Comparison of pre-analytical characteristics for molecular and serological diagnostics of COVID-19
Copan eNAT Transport System to Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access
Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR
So Yeon Kim
COVID-19 Emergency Management: From the Reorganization of the Endoscopy Service to the Verification of the Reprocessing Efficacy
Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic
Mario Poljak, Miša Korva, Nataša Knap Gašper, Kristina Fujs Komloš, Martin Sagadin, Tina Uršič, Tatjana Avšič Županc, Miroslav Petrovec
Monitoring COVID-19 Transmission Risks by Quantitative Real-Time PCR Tracing of Droplets in Hospital and Living Environments
Andrea Piana, Maria Eugenia Colucci, Federica Valeriani, Adriano Marcolongo, Giovanni Sotgiu, Cesira Pasquarella, Lory Marika Margarucci, , Andrea Petrucca, Gianluca Gianfranceschi, Sergio Babudieri, Pietro Vitali, Giuseppe D’Ermo, Assunta Bizzarro, Flavio De Maio, Matteo Vitali, Antonio Azara, Ferdinando Romano, Maurizio Simmaco, Vincenzo Romano Spica
Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients
Fei Yu et al.
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
Konstantinos Tsiakos et al.
Real-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage
Bogdan C. Pana et al.
Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19
Eugenia Maiorano et al.
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs
Cedric Hartard et al.
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
Victor M Corman, Verena Claudia Haage, Tobias Bleicker, Marie Luisa Schmidt, Barbara Mühlemann, Marta Zuchowski, Wendy K Jo, Patricia Tscheak, Elisabeth Möncke-Buchner, Marcel A Müller, Andi Krumbholz, Prof Jan Felix Drexler, Prof Christian Drosten
Comparative Analysis of Primer−Probe Sets for RT-qPCR of COVID19 Causative Virus (SARS-CoV-2)
Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic
Andrea Orsi et al.
Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing
Daniela Loconsole et al.
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?
Daniel G. Federman , Shaili Gupta,Gary Stack, Sheldon M. Campbell, David R. Peaper, Louise M. Dembry, Ann Fisher, Asim F. Tarabar, Michael Kozal, Christopher B. Ruser
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection
Gabriele Bianco, Matteo Boattini, Anna Maria Barbui, Gitana Scozzari, Franco Riccardini, Maurizio Coggiola, Enrico Lupia, Rossana Cavallo, Cristina Costa
Sports balls as potential SARS-CoV-2 transmission vectors
Michel Pelisser et al.
Excellent option for mass testing during the SARS‑CoV‑2 pandemic: painless self‑collection and direct RT‑qPCR
Eva Kriegova et al.
Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience
Emerenziana Ottaviano et al.
Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV‑2 Patients
Bart Van Puyvelde et al.
Safe and effective pool testing 1 for SARS-CoV-2 detection
Marie Wunsch et al.
Practical strategies for SARS-CoV-2 RT-PCR testing in resource-constrained settings
Meredith S. Muller et al.
Low Rate of SARS-CoV-2 Infections in Symptomatic Patients Attending a Pediatric Emergency Department
Christoph Zurl, Ernst Eber, Anna Siegl, Sabine Loeffler, Evelyn Stelzl, Harald H. Kessler, Markus Egger, Nina A. Schweintzger, Werner Zenz, Volker Strenger
Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 by Use of Real-Time Reverse Transcription-PCR
Amy A. Rogers, Russell E. Baumann, Gwynngelle A. Borillo, Ron M. Kagan, Hollis J. Batterman, Marzena M. Galdzicka, Elizabeth M. Marlowe
Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa
Self‑sampling versus health care professional‑guided swab collection for SARS‑CoV‑2 testing
An in-well direct lysis method for rapid detection of SARS-CoV-2 by real time RT-PCR in eSwab specimens
Rikke Lind Jørgensen
Performance of the RT-LAMP-based eazyplex® SARS-CoV-2 as a novel rapid diagnostic test
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
How home anterior self-collected nasal swab simplifies SARS-CoV-2 testing: new surveillance horizons in public health and beyond
Silvia Ricci, Lorenzo Lodi, Francesco Citera, Francesco Nieddu, Maria Moriondo, Valentina Guarnieri, Mattia Giovannini, Giuseppe Indolfi, Massimo Resti, Alberto Zanobini, Chiara Azzari
ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections
Luca Marcolungo, Cristina Beltrami , Chiara Degli Esposti, Giulia Lopatriello, Chiara Piubelli, Antonio Mori, Elena Pomari, Michela Deiana, Salvatore Scarso, Zeno Bisoffi, Valentina Grosso, Emanuela Cosentino, Simone Maestri, Denise Lavezzari, Barbara Iadarola, Marta Paterno, Elena Segala, Barbara Giovannone, Martina Gallinaro, Marzia Rossato, Massimo Delledonne
Detection of Microbial Agents in Oropharyngeal and Nasopharyngeal Samples of SARS-CoV-2 Patients
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2
Byron M. Berenger, John M. Conly, Kevin Fonseca, Jia Hu, Thomas Louie, Angela R. Schneider, Takshveer Singh, William Stokes, Linda Ward, Nathan Zelyas
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing
David van Bockel
Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays
Robust and sensitive detection of SARS-CoV-2 using PCR based methods
Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction 2 reagents, detergents and fixatives
Stephen R. Welch
Efficient SARS-CoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex™ 2019-nCoV assay
Wesley Freppel, Natacha Merindol, Fabien Rallu, Marco Bergevin
Monitoring environmental contamination caused by SARS-CoV-2 in a healthcare facility by using adenosine triphosphate testing
Justin J. Kim
Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA
Richard J. Drew
Assessment of the direct quantitation of SARS-CoV-2 by droplet digital PCR
Michela Deiana, Antonio Mori, Chiara Piubelli, Salvatore Scarso, Mosè Favarato, Elena Pomari
Congresso Nazionale della Società Italiana di Microbiologia
49th SIM 2021 Congress will aim to take stock of the situation on research, at two different times.
The first will take place over two days dedicated to the presentation of posters and the second on 20 and 21 September for the oral sessions. In particular, the days of 16 and 17 September will be dedicated to e-Posters, with data from SIM research in all its facets, to try to take stock of the post-covid era and how to build it. In the two days of oral sessions, on the other hand, national experts will deal with the hottest topics of the day, from SARS-Cov-2 to vaccines, from diagnostics to pathogenesis and resistance, from fungi to rapid diagnostics.
Asia Pacific Congress of Clinical Microbiology and Infection – APCCMI
APCCMI 2021 will build on this rich history in Singapore and regional collaboration. The congress will focus on:
- Advances in infection control, microbiome and vaccines; new antimicrobials and antimicrobial stewardship.
- Advances in microbiology including rapid diagnostics, applications in whole-genome sequencing, laboratory automation;
- Antimicrobial resistance in humans and within the One Health context of animals, humans and the environment;
- Challenges and progress in the three pandemic infections of HIV, Malaria, and Tuberculosis;
- Emerging infectious diseases prevalent in the region (Chikungunya, Dengue, Zika) and globally (Avian and seasonal influenza, MERS-CoV)
The 6th International Conference on Prevention & Infection Control (ICPIC), which will be held on 14-17 September 2021.
After the challenging past year through the COVID-19 pandemic, the need to bring together the global IPC community becomes even stronger. We believe that all required conditions will be met next September to be able to organize a safe, interactive and stimulating face-to-face conference.
Launch of PodSwab™ – UTM® for pooling
Many scientific studies have demonstrated pooled testing to be an efficient methodology for screening in the case of low-incidence phases of COVID-19. We are now ready to present PodSwab™ – UTM® for pooling: another Copan solution to streamline laboratory workflow in COVID-19 screening.
Launch of LolliSponge™
We are proud to present LolliSponge™, the new sponge-made saliva collection device we conceived by listening to the healthcare professionals’ needs!
LolliSponge™ easiness allows saliva collection from non-collaborative patients or when professional assistance is not available, enabling COVID-19 active surveillance programs in fragile communities and making personnel available for other activities such as vaccine administration.
Microbiology Time – August 2021
It’s August Microbiology Time! We just updated our website’s scientific database and chose the best three papers of the month: a study on extrapulmonary samples processing with MycoTB™, an alternative to PCR for Sars-CoV-2 diagnosis, and the first feedback from the LolliSponge™ use to collect saliva for COVID-9 screening.
CoHere: Copan at ECCMID 2021
ECCMID 2021 is approaching! ECCMID is the event we have been waiting for all year round, as it’s the main occasion to gather with you all clients and collaborators and an excellent chance to share the latest findings and developments in microbiology. Discover what we arranged for the event!
Microbiology Time – September 2021
We just updated our scientific studies database with numerous studies. This month’s top picks analyze SRK® sample stability, SARS-CoV-2 self-collection FLOQSwabs®, and antibiotic resistances in Belgian and Dutch farms.
Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario
With an email to the main distributors, Copan group’s CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges.
Last Tuesday, Copan partners received an email signed by Copan’s CEO Stefania Triva herself. Certainly, it was not the first email they received from the leader in preanalytics last year. Still, this time the communication tried to put a full stop to pandemic-related struggles, informing about the accomplishment of 2020 common goals and reorganizing the company and its network for the years to come.
Copan Response to the Pandemic and our Efforts to Fight COVID-19 Worldwide
When supermarket shelves across the country were suddenly bare — and people were clamoring for essentials like toilet paper — everyone learned a little more than they wanted to about the importance of supply chains.
Moving ahead: Copan announces a major rebranding and launches a new website
Time of change for Copan. The Italian preanalytics company announced the completion of an extensive rebranding initiative which includes a new logo and a new website with updated functionalities. The rebranding aims to represent at best the company values and offer an improved customer experience.
Copan’s global response to COVID-19
To react to the extraordinary demand for our SARS-CoV-2 collection kits caused by the current pandemic, at Copan we have rethought our approach to every side of our activity. Although the emergency is still far from being over, we are committed to facing it with the motivation that has always distinguished us.
Integrated Symposium ECCMID 2021
The challenges of managing the COVID-19 pandemic from preanalytics to diagnosis
Dr. Paolo Gaibani explores how lab automation has helped molecular biology labs face the increasing volumes of samples received during the pandemic.
From the pandemic and beyond
During 2020 we faced the pandemic head-on, boosting our COVID-related production capacity and bringing our manufacturing sites closer to the end-markets. But how we did that? Of course, putting the safety and welfare of our employees first.
Copan’s international family has grown and is ready to face what the future will bring!
Nasopharyngeal Collection with FLOQSwabs® and UTM®
A proper nasopharyngeal specimen sampling is crucial for a correct diagnosis of respiratory tract infections, including COVID-19. To help the collection of SARS-CoV-2 in compliance with CDC and WHO guidelines, we created this how-to educational video.
Universal transport media
Flash Session ECCMID 2021
Listening to the needs of healthcare professionals: Copan’s innovative approach to the pandemic
A deep dive into our latest projects, such as the release of UniVerse™, LolliSponge™, and our recent rebranding.